TB-ricc 3.0 is designed to support the regional prospective observational research tuberculosis (report) consortium to produce the highest quality observational and interventional research on…
Active Cooperative Agreement Awarded Last action
- Award ID
- U01AI174268
- Recipient
-
Rutgers The State University Of New Jersey UEI YVVTQD8CJC79
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $31,482,749
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 71% complete
- Place of performance
- Newark, NJ 07107, USA
Award details come from USAspending.gov.
Description
TB-ricc 3.0 is designed to support the regional prospective observational research tuberculosis (report) consortium to produce the highest quality observational and interventional research on tuberculosis (TB), TB-HIV, and TB-covid-19. To accomplish this goal, TB-ricc 3.0 will: i) collaborate with report country-network data centers and biorepositories to ensure that common data elements (CDE) of the common protocol and specimen tracking are accessible through the global data template; II) organize and/or strengthen select sites to participate in diagnostic studies and clinical trials; and III) support the report country-networks to ensure further development of TB diagnostic laboratories, TB- ricc 3.0 specialized laboratories, and biorepositories. Aims of TB-ricc 3.0 are: coordinating center structure and function: develop a leadership group and executive committee; assure effective communication internally and externally; establish a data hub to provide seamless data management from collection to analysis; establish scientific working groups; a scientific review committee and an administrative core; facilitate grant submissions to potential funders and partners. Data harmonization: develop a data hub to collaborate with country-level data centers to facilitate multiregional data workflow using the redcap harmonist platform and other tools; research: catalyze TB, TB/HIV and TB/covid-19 research within and across report country networks, and with external partners; prioritize study of TB close contacts to evaluate biomarkers predictive of progression to TB across three "omics" platforms and three continents; capacity building: develop modular remote courses for capacity building in the components of TB research; mentor early-stage investigator (ESI) development. TB-ricc 3.0 will deliver high-impact innovative research to advance TB science and TB control
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $3,876,853 | |
| Amendment | $3,925,093 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $3,960,184 | |
| Amendment | $3,960,184 | |
| Amendment | $3,960,184 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $3,933,417 | |
| Amendment | $3,933,417 | |
| Original award | $3,933,417 |
Show all 14
Subawards
Show all 21
Quick answers
Who received award U01AI174268?
U01AI174268 was awarded to Rutgers The State University Of New Jersey by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2023.
How much is award U01AI174268 worth?
$31,482,749 has been obligated on U01AI174268.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award